Mitigating effects of dialysable leukocyte extract (DLE) on the experimental allergic uveitis (EAU) of the rabbit.
Experimental allergic uveitis (EAU) is an induced autoimmune disease by administering soluble retinal S antigen and complete Freund's adjuvant (CFA). In rabbits, the result is the occurrence of chorioretinitis in 90% of the cases. The first inflammation is followed by spontaneous relapses. The EAU of the rabbit was utilized to study the effects of the dialyzable leucocyte extract (DLE) on the course and the intensity of the disease in this autoimmune model. The DLE preparations examined differed with regard to their origin or the immunological stimulation of the initial material (DLE from humans (DLE Hu) and DLE from the normal rabbit (DLE RaO) or rabbits which had EAU (DLE RaEAU) and rabbits which had received CFA (DLE Ra (CFA). One unit of DLE corresponds to the extract from 10(9) cells. The administration of DLE starts with the onset of inflammation. 4 x 0.5 units were administered during the first week, 1 x 0.5 units per week from the 2nd to the 12th week. All preparations decrease the cumulative frequency of the days of illness significantly. The duration of the initial inflammation is reduced in all animals treated, but only in part significantly. There appears a graduation of efficacy: DLE RaEAU greater than DLE Ra CFA greater than DLE Hu greater than DLE RaO. Overall, it can be seen that, on the one hand, there is no specificity or restriction of the species for the efficacy and, on the other hand, the extent of the effects depends on the degree of the immunological stimulation. The maximum efficacy of DLE RaEAU is not exclusively due to the transmission of an antigen-specific sensitization.(ABSTRACT TRUNCATED AT 250 WORDS)
Fricke
H J
HJ
Department of Ophthalmology, Friedrich Schiller University, Jena, Federal Republic of Germany.
Schröder
K D
KD
Metzner
G
G
Schröder
I
I
Haroske
D
D
Tilgner
S
S
Sych
F J
FJ
Klein
S
S
Jäger
L
L
D000818:Animals; D000941:Antigens / Q000276:immunology; D019393:Arrestin; D001327:Autoimmune Diseases / Q000628:therapy*; D002457:Cell Extracts; D003956:Dialysis; D004195:Disease Models, Animal; D005136:Eye Proteins / Q000276:immunology; D007155:Immunologic Factors / Q000302:isolation & purification / Q000627:therapeutic use*; D007962:Leukocytes / Q000737:chemistry*; D011817:Rabbits; D014605:Uveitis / Q000628:therapy*
D000941:Antigens; D019393:Arrestin; D002457:Cell Extracts; D005136:Eye Proteins; D007155:Immunologic Factors